A prognostic nomogram for neuroblastoma in children.

Area of Science:

• Pediatric Oncology
• Cancer Prognostics
• Biostatistics

Background:

• Neuroblastoma is a common pediatric extracranial solid tumor, representing 7-10% of childhood cancers.
• Accurate prognosis is crucial for optimizing treatment efficacy and minimizing long-term complications in high-risk neuroblastoma patients.

Purpose of the Study:

• To develop and validate a predictive nomogram for estimating the overall survival (OS) of childhood neuroblastoma patients.
• To compare the predictive performance of the developed nomogram against established staging systems.

Main Methods:

• Utilized data from 757 neuroblastoma patients diagnosed between 1986 and 2012 from the TARGET database.
• Employed COX regression analysis to identify risk factors and construct a nomogram for survival prediction.
• Evaluated nomogram precision using concordance index (C-index) and area under the receiver operating characteristic (ROC) curve (AUC) for 3- and 5-year survival.

Main Results:

• Multivariate analysis identified age at diagnosis (>520 days), stage 4 (INSS), and DNA ploidy as independent predictors of OS.
• The nomogram achieved a C-index of 0.704 in the training cohort and 0.672 in the validation cohort.
• The nomogram demonstrated superior predictive power compared to the International Neuroblastoma Staging System (INSS), tumor histology, and Children's Oncology Group (COG) risk group.

Conclusions:

• The developed nomogram provides a more accurate prognostic tool for childhood neuroblastoma than current systems.
• Precise survival estimates from this nomogram can significantly aid clinicians in making informed treatment decisions.
• This tool has the potential to improve outcomes for children diagnosed with neuroblastoma.